Physician profile
Michael Thompson
NPI 1346627841
$4,187.01
in general payments reported to CMS, 2019-2025
17 companies · $395 in 2025
The $395 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $283 · 2022: $1,437 · 2023: $1,626 · 2024: $447 · 2025: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,940 · Travel and Lodging: $527.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,939.91 |
| Travel and Lodging | $527.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $1,733.50 | 2021-2025 | Atriclip Laa Exclusion System, Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax |
| Boston Scientific Corporation | $1,420.73 | 2023-2025 | Watchman Access System, Watchman Flx, Resonate El Icd Vr |
| Abbott Laboratories | $328.79 | 2022-2023 | Mitraclip |
| Abiomed | $238.93 | 2023-2024 | Impella |
| Lexicon Pharmaceuticals, INC. | $121.82 | 2023 | Inpefa |
| Biosense Webster, INC. | $77.24 | 2022 | |
| Janssen Pharmaceuticals, INC | $50.91 | 2023-2024 | Xarelto |
| Biotronik INC. | $40.97 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $29.59 | 2024 | Arcalyst |
| Cvrx, INC. | $27.03 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $19.24 | 2023 | Opsumit |
| E.R. Squibb & Sons, L.L.C. | $19.05 | 2023 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.31 | 2024 | Jardiance |
| Pfizer INC. | $18.18 | 2023 | |
| Novo Nordisk INC | $16.80 | 2024 | Wegovy |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $14.09 | 2021 | |
| Amgen INC. | $11.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.